| Symbol | Company | Weighting |
|---|---|---|
| INSM | INSMED INC | 6.83% |
| NTRA | NATERA INC | 4.29% |
| THC | TENET HEALTHCARE CORP | 4.22% |
| EXEL | EXELIXIS INC | 3.44% |
| ALNY | ALNYLAM PHARMACEUTICALS INC. | 3.15% |
| MASI | MASIMO CORP | 2.96% |
| ISRG | INTUITIVE SURGICAL INC | 2.83% |
| ASND | ASCENDIS PHARMA A/S DKK 1.0 ADR | 2.79% |
| MCK | MCKESSON CORP | 2.71% |
| BBIO | BRIDGEBIO PHARMA INC | 2.53% |
| COR | CENCORA INC | 2.41% |
| HCA | HCA HOLDINGS INC | 2.34% |
| ABBV | ABBVIE INC | 2.19% |
| VRTX | VERTEX PHARMACEUTICALS INC | 2.08% |
| LLY | ELI LILLY CORP | 2.06% |
| SNN | SMITH & NEPHEW PLC | 1.98% |
| NBIX | NEUROCRINE BIOSCIENCES INC | 1.87% |
| RVTY | REVVITY INC | 1.86% |
| ARGX | ARGENX SE ADR | 1.85% |
| JNJ | JOHNSON & JOHNSON | 1.83% |
| AZN | ASTRAZENECA PLC-ADR | 1.82% |
| STE | STERIS PLC | 1.76% |
| AMGN | AMGEN CORP | 1.75% |
| CYTK | CYTOKINETICS INC | 1.75% |
| CRNX | CRINETICS PHARMACEUTICALS INC | 1.74% |
| ALKS | ALKERMES INC | 1.73% |
| XENE | XENON PHARMACEUTICALS | 1.64% |
| CRL | CHARLES RIVER LABORATORIES INT INC | 1.58% |
| DHR | DANAHER CORP | 1.57% |
| INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.56% |
| IQV | IQVIA HOLDINGS INC | 1.52% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.49% |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1.44% |
| DXCM | DEXCOM INC | 1.43% |
| BAX | BAXTER INTERNATIONAL INC | 1.37% |
| ZTS | ZOETIS INC | 1.36% |
| BIO | BIO-RAD LABORATORIES INC | 1.34% |
| MRK | MERCK & CO. NEW | 1.30% |
| AVTR | AVANTOR, INC. | 1.22% |
| PCVX | VAXCYTE INC | 1.18% |
| WST | WEST PHARMACEUTICAL SERVICES INC | 1.16% |
| DNLI | DENALI THERAPEUTICS INC. | 1.15% |
| NVO | NOVO NORDISK A/S | 1.15% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.14% |
| BMRN | BIOMARIN PHARAMCEUTICAL INC | 1.10% |
| REGN | REGENERON PHARMACEUTICALS | 1.06% |
| BIIB | BIOGEN INC | 0.92% |
| ELV | ELEVANCE HEALTH INC | 0.90% |
| UNH | UNITEDHEALTH GROUP INC | 0.88% |
| IMVT | IMMUNOVANT INC | 0.77% |
| HUM | HUMANA INC | 0.74% |
| MOH | MOLINA HEALTHCARE INC | 0.73% |
| MDRX | VERADIGM INC | 0.58% |
| ACHC | ACADIA HEALTHCARE CO INC | 0.49% |
| SRPT | SAREPTA THERAPEUTICS INC | 0.23% |
| RCKT | ROCKET PHARMACEUTICALS INC USD | 0.23% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.